|
Sep 4
|
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer
|
|
Aug 31
|
Biomerica Full Year 2024 Earnings: US$0.35 loss per share (vs US$0.50 loss in FY 2023)
|
|
Aug 29
|
Biomerica Reports Fiscal 2024 Year End Results
|
|
May 13
|
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
|
|
Apr 29
|
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
|
|
Apr 15
|
Biomerica provides update on inFoods® IBS expansion
|
|
Apr 12
|
Biomerica Reports Third Quarter 2024 Financial Results
|
|
Mar 28
|
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
|
|
Jan 16
|
Biomerica Reports Second Quarter 2024 Financial Results
|
|
Dec 20
|
Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?
|
|
Dec 18
|
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
|
|
Nov 10
|
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
|
|
Nov 8
|
Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
|